The Tumor Immune Microenvironment and Frameshift Neoantigen Load Determine Response to PD-L1 Blockade in Extensive-Stage SCLC

INTRODUCTION: Despite a considerable benefit of adding immune checkpoint inhibitors (ICIs) to platinum-based chemotherapy for patients with extensive-stage SCLC (ES-SCLC), a durable response to ICIs occurs in only a small minority of such patients. METHODS: A total of 135 patients with ES-SCLC treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanemura, Hiroaki, Hayashi, Hidetoshi, Tomida, Shuta, Tanizaki, Junko, Suzuki, Shinichiro, Kawanaka, Yusuke, Tsuya, Asuka, Fukuda, Yasushi, Kaneda, Hiroyasu, Kudo, Keita, Takahama, Takayuki, Imai, Ryosuke, Haratani, Koji, Chiba, Yasutaka, Otani, Tomoyuki, Ito, Akihiko, Sakai, Kazuko, Nishio, Kazuto, Nakagawa, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356091/
https://www.ncbi.nlm.nih.gov/pubmed/35941997
http://dx.doi.org/10.1016/j.jtocrr.2022.100373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356091/
https://www.ncbi.nlm.nih.gov/pubmed/35941997
http://dx.doi.org/10.1016/j.jtocrr.2022.100373

Ejemplares similares